National Drug Code (NDC) Database
Bobbi Brown Professional Cosmetics Inc.
-
NDC:
64141-902
-
Nonproprietary Name:
octinoxate, titanium dioxide
-
Dosage Form:
EMULSION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
67; 16 g/kg; g/kg
-
Substance:
OCTINOXATE; TITANIUM DIOXIDE
-
Start Marketing Date:
2024-12-20
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Boehringer Ingelheim Biopharmaceuticals (China) Ltd.
-
NDC:
77657-020
-
Nonproprietary Name:
tislelizumab
-
Dosage Form:
LIQUID
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
100 mg/100mg
-
Substance:
TISLELIZUMAB
-
Start Marketing Date:
2023-05-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Boehringer Ingelheim España, S.A.
-
NDC:
83248-040
-
Nonproprietary Name:
empagliflozin
-
Dosage Form:
TABLET
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
25 mg/25mg
-
Substance:
EMPAGLIFLOZIN
-
Start Marketing Date:
2014-08-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Boehringer Ingelheim Fremont, Inc.
-
NDC:
83012-052
-
Nonproprietary Name:
Aflibercept
-
Dosage Form:
LIQUID
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
65 mg/mL
-
Substance:
AFLIBERCEPT
-
Start Marketing Date:
2026-03-19
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
BOEHRINGER INGELHEIM HELLAS SINGLE MEMBER S.A.
-
NDC:
83145-015
-
Nonproprietary Name:
empagliflozin
-
Dosage Form:
TABLET, FILM COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
25 mg/25mg
-
Substance:
EMPAGLIFLOZIN
-
Start Marketing Date:
2014-08-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Boehringer Ingelheim Pharma GmbH and Co. KG
-
NDC:
12714-932
-
Nonproprietary Name:
telmisartan
-
Dosage Form:
TABLET
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
80 mg/80mg
-
Substance:
TELMISARTAN
-
Start Marketing Date:
2000-12-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Boehringer Ingelheim Promeco S.A. de C.V.
-
NDC:
64674-999
-
Nonproprietary Name:
Linsgliptin
-
Dosage Form:
TABLET
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
5 mg/5mg
-
Substance:
LINAGLIPTIN
-
Start Marketing Date:
2022-12-28
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Boehringer Ingelheim RCV GmbH & Co KG
-
NDC:
68594-130
-
Nonproprietary Name:
Trastuzumab deruxtecan
-
Dosage Form:
POWDER, FOR SOLUTION
-
Product Type:
BULK INGREDIENT
-
Strength:
22 g/22g
-
Substance:
TRASTUZUMAB DERUXTECAN
-
Start Marketing Date:
2025-09-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Boiron
-
NDC:
0220-0154
-
Nonproprietary Name:
AILANTHUS ALTISSIMA FLOWERING TWIG
-
Dosage Form:
LIQUID
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
1
-
Substance:
AILANTHUS ALTISSIMA FLOWERING TWIG
-
Start Marketing Date:
2018-09-20
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Bond Pharmacy INC
-
NDC:
81371-7005
-
Nonproprietary Name:
Clonidine Hydrochloride
-
Dosage Form:
INJECTION, SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
5 mg/mL
-
Substance:
CLONIDINE HYDROCHLORIDE
-
Start Marketing Date:
2021-05-03
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.